Systemic vasculitis--is it time to reclassify?

Systemic vasculitis--is it time to reclassify?

Bibliográfalaš dieđut
Váldodahkkit:	Watts, R, Suppiah, R, Merkel, P, Luqmani, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2011

Geahča maid

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2011)

Advances in the classification of primary systemic vasculitis
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2009)

The need for diagnostic criteria in systemic vasculitis
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

REVIEW OF THE EXPERT PANEL METHODOLOGY IN THE DIAGNOSTIC AND CLASSIFICATION CRITERIA FOR VASCULITIS STUDY: A PILOT STUDY
Dahkki: Pante, C, et al.
Almmustuhtton: (2014)

Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study
Dahkki: Ponte, C, et al.
Almmustuhtton: (2013)

Cutaneous manifestations of ANCA-associated vasculitis
Dahkki: Chiesafuxench, Z, et al.
Almmustuhtton: (2016)

Outcome measures in ANCA-associated vasculitis.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
Dahkki: Craven, A, et al.
Almmustuhtton: (2013)

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease
Dahkki: Micheletti, R, et al.
Almmustuhtton: (2017)

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
Dahkki: Seeliger, B, et al.
Almmustuhtton: (2017)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
Dahkki: Pearce, F, et al.
Almmustuhtton: (2016)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
Dahkki: Pearce, F, et al.
Almmustuhtton: (2017)

Treatment of vasculitis in rheumatoid arthritis.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (1994)

Disease assessment in systemic vasculitis
Dahkki: Luqmani, R
Almmustuhtton: (2004)

Assessment of damage in vasculitis: expert ratings of damage.
Dahkki: Seo, P, et al.
Almmustuhtton: (2009)

Assessment of damage in vasculitis: Expert ratings of damage
Dahkki: Seo, P, et al.
Almmustuhtton: (2008)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
Dahkki: Floris, A, et al.
Almmustuhtton: (2016)

284 Differences in early damage patterns in various forms of primary systemic vasculitis
Dahkki: Wawrzycka-Adamczyk, K, et al.
Almmustuhtton: (2016)

Using the Birmingham Vasculitis Activity Score as a Screening Tool in Patients with Suspected Vasculitis
Dahkki: Floris, A, et al.
Almmustuhtton: (2016)

Outcome in systemic vasculitis.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (1998)

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
Dahkki: Merkel, P, et al.
Almmustuhtton: (2011)

Accuracy of renovo predictions on variants reclassified over time
Dahkki: Emanuele Bonetti, et al.
Almmustuhtton: (2024-07-01)

NEW INSIGHTS INTO THE MANAGEMENT OF SYSTEMIC VASCULITIS
Dahkki: Luqmani, R
Almmustuhtton: (2012)

Vasculitis: an update.
Dahkki: Luqmani, R
Almmustuhtton: (2014)

Vasculitis: an update.
Dahkki: Luqmani, R
Almmustuhtton: (2014)

Cyclophosphamide and systemic vasculitis.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (1993)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

OP0055 Using the Birmingham Vasculitis Activity Score as a screening tool in patients with suspected vasculitis
Dahkki: Floris, A, et al.
Almmustuhtton: (2016)

Assessment of systemic vasculitis.
Dahkki: Miller, A, et al.
Almmustuhtton: (2008)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Discontinuation of therapies in vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

Discontinuation of therapies in vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

Discontinuation of therapies in vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
Dahkki: Luqmani, R
Almmustuhtton: (2012)

Malignant pheochromocytoma with negative biochemical markers: Is it time to reclassify pheochromocytomas?
Dahkki: Shiva Borzouei, et al.
Almmustuhtton: (2019-05-01)

Outcome in small-vessel systemic vasculitis.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2006)

Mortality in systemic vasculitis: a systematic review.
Dahkki: Phillip, R, et al.
Almmustuhtton: (2008)

Cardiovascular involvement in primary systemic vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Is it possible to offer evidence-based treatment for systemic vasculitis?
Dahkki: Luqmani, R
Almmustuhtton: (2000)